Skip to main content
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. — Investor Relations & Filings

Ticker · LEXX ISIN · US52886N4060 US Professional, scientific and technical activities
Filings indexed 1,010 across all filing types
Latest filing 2025-06-12 Regulatory Filings
Country US United States of America
Listing US LEXX

About Lexaria Bioscience Corp.

https://www.lexariabioscience.com/

Lexaria Bioscience Corp. is a biotechnology company focused on the development and commercialization of its patented drug delivery platform, DehydraTECH™. This technology is designed to improve the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral administration. DehydraTECH™ enhances the bioavailability of APIs, which can enable faster absorption, increased efficacy, and the potential for reduced drug dosages. The company operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with numerous patents granted globally for its platform technology.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events or material definitive agreements. The text describes the entry into a material definitive agreement (a Change Order to a Project Agreement) related to a clinical study. It references that the full agreement will be filed as an exhibit to the company's quarterly 10-Q report, indicating this is an announcement of a material event rather than a full financial report or detailed management discussion. The document length is 4090 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories like Annual Report, Earnings Release, or Management Reports.
2025-06-12 English
PRIMARY DOCUMENT
Director's Dealing
2025-05-16 English
PRIMARY DOCUMENT
Director's Dealing
2025-05-16 English
PRIMARY DOCUMENT
Director's Dealing
2025-05-16 English
PRIMARY DOCUMENT
Director's Dealing
2025-05-16 English
PRIMARY DOCUMENT
Director's Dealing
2025-05-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.